Voya (VOYA) Q4 2025 Earnings Call Transcript

Voya Financial delivered over $1 billion of pretax adjusted operating earnings in 2025, up $168 million year over year, while EPS rose 22% to $8.85 and excess capital generation reached $775 million, above target. Retirement and Investment Management combined assets surpassed $1 trillion, DC net flows hit a record $28 billion, and Investment Management generated $1 billion+ of net revenues with $360 billion in AUM. Management sounded constructive on 2026, guiding to further excess capital growth and $150 million of share repurchases in both Q1 and Q2, though Stop Loss remains the main risk due to elevated healthcare claims volatility and reserve uncertainty.

Analysis

The cleanest read-through is that the market is likely underestimating the durability of Voya’s cash conversion. The combo of higher-rate repricing in Stop Loss, better risk selection, and a growing retirement fee base creates an unusually strong offset to what is otherwise a cyclical healthcare-claims problem. That matters because the operating leverage is now visible at the consolidated level: incremental margin in Employee Benefits can drop through to excess capital generation, which directly supports buybacks and should compress the stock’s implied risk premium.

The bigger second-order effect is competitive: management is signaling that employer uncertainty around medical spend is pushing demand toward bundled workplace solutions. That can help Voya gain wallet share even if it deliberately sacrifices some growth on the margin line, and it also strengthens cross-sell into retirement and wealth relationships through the same broker and consultant channels. In other words, Stop Loss is not just an earnings line item; it is a lead-generation and distribution wedge that may improve retention and account penetration across the franchise.

The main near-term risk is that investors anchor on the reserve build and interpret it as a sign the loss environment is still worsening, when the more important variable is whether paid claims continue to develop inside the company’s widened reserve band over the next 1-2 quarters. If first-quarter development confirms the low-single-digit favorable trend they described, the stock likely re-rates quickly because the debate shifts from solvency/credibility to capital return cadence. If not, the downside is less about franchise value and more about multiple compression as the market prices in another year of reserve noise.

Contrarian angle: the consensus probably overweights Stop Loss volatility and underweights the structural value of the Retirement/IM cash engine. At roughly 19% ROE and a buyback-first capital plan, Voya is starting to look more like a capital-return compounder than a pure insurance story. The stock should trade less on quarterly claims drama and more on whether excess capital can be sustained above the $700M-plus level while DC flows and IM organic growth stay above trend.

Key Decisions for Investors

• Long VOYA into the next 1-2 quarters, targeting a rerating if Q1 paid-claims development confirms low-single-digit improvement; stop if reserve commentary worsens or capital return guidance is cut.
• Buy VOYA Jan-2027 call spreads or risk reversals to express a benign Stop Loss resolution and buyback-driven upside with defined downside over the next 6-12 months.
• Pair trade: long VOYA vs. short a less diversified benefits/managed-retirement peer with weaker cash conversion; thesis is that Voya’s excess capital and recurring fee mix deserve a premium multiple.
• Add on any selloff tied to Stop Loss headlines if the stock de-rates >8-10% without evidence of worsening paid claims; risk/reward improves because downside is likely sentiment-driven while upside is fundamental.
• For accounts seeking lower beta financials exposure, initiate a modest core long and look to trim only if Q1 reserve credibility is not validated by reported claim development.